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Abstract
The SARS-CoV-2 infection, which causes the coronavirus disease (COVID-19), has affected lives, with very adverse outcomes
in specific populations in the United States of America (USA), a high-income country, and two middle-income countries, Brazil
and South Africa. This paper aims to discuss the relationship of race/ethnicity with COVID-19-associated factors in the three
countries. The information is based on data collected from infectious disease/epidemiological centers in the USA, Brazil, and
South Africa. Adverse COVID-19 outcomes have been associated with the burden of exposure and disease, linked to socioeco-
nomic determinants, among specific ethnicities in all three countries. The prevalence of comorbidities before and the likelihood
of work-related exposure in the context of COVID-19 infection puts ethnic minorities in the USA and some ethnic majorities and
minorities in Brazil and South Africa at greater risk. We envisage that this work will contribute to ongoing discussions related to
addressing socioeconomic determinants of health, and the need for stakeholders in various sectors to work on addressing
observed health disparities for overall improvement in health and healthcare given the current pandemic.
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Introduction
The severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection, which causes the coronavirus disease
(COVID-19), is a threat to global health. In this extended
commentary, racial disparities in health and COVID-19 out-
comes are compared across three countries: South Africa,
Brazil, and the United States of America (USA). At the time
of writing (September 2020), the USA, a high-income coun-
try, and two middle-income countries, Brazil and South
Africa, were among the top ten countries with the highest
number of cumulative COVID-19 confirmed cases
(6,662,003, 4,495,183, and 659,656, respectively) and deaths
(197,442, 135,793, and 15,940, respectively) in their corre-
sponding continents [1]. In earlier studies, these countries
have been used to present cases of racial stratifications
[2–6]. For this extended commentary, we selected these coun-
tries, as examples where inequalities exist along ethnic lines in
their respective continents, to explore disparities in COVID-
19 outcomes using available data. These characteristics and
experiences of the coronavirus pandemic provide a platform
on which comparisons can be made. Such comparison does
not negate the fact that differences exist in history and context
across the three countries and such differences may have roles
in the respective COVID-19-related outcomes.
Factors related to demographics and comorbid conditions
are linked to the vulnerability of specific ethnicities to
COVID-19 complications [7–11]. In these populations, the
burden of other diseases has been attributed to socioeconomic
determinants of health [12–14], which are thought to have
some bearing on adverse COVID-19 outcomes (10).
Comorbidities such as diabetes mellitus, hypertension, obesi-
ty, the human immunodeficiency virus (HIV), and tuberculo-
sis (TB) infections have been shown to increase the risk of
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severe COVID-19 disease and mortality in the three countries
[7–9, 15]. These comorbidities, which predispose to COVID-
19 complications, had earlier been noted in individuals of
African descent and some minority groups in the USA,
Brazil, and South Africa [16–18], who also have poorer health
outcomes, higher overall mortality, and lower life expectancy
compared to Caucasians/Whites [13, 16–19]. These
preexisting health disparities, in addition to exposure at home
or at work, are believed to contribute to their disproportion-
ately higher COVID-19-related deaths in the three countries.
Prepandemic Health Disparities
The relatively higher burden of chronic diseases, among spe-
cific ethnicities in the three countries, is believed to reflect
lower access to healthcare, primary care providers, or disease
prevention strategies [12, 13, 18, 20]. In the USA, the 2018
data depicting uninsured rates among non-elderly individuals
(up to 64 years old) were higher for minority populations such
as American Indians and Alaska Natives (AIAN) at 21.8%,
Hispanics (19%), and Blacks (11.5%) compared with Whites
(7.5%) [21]. In the 2018 General Household Survey in South
Africa, 9.9% of Black South Africans were noted to have
medical insurance cover compared to 17.1% of Coloreds,
52% of Indians/Asians, and 72.9% of Whites [22]. In Brazil,
analysis of the 2010 data on elderly access to health services in
São Paulo showed that populations classified as Black
(74.3%) or Brown (69.8%) were more likely to be uninsured
compared to Whites (46.9%) [2]. The COVID-19
virus outbreak is the most recent in a list of health issues that
disproportionately affect these specific vulnerable populations
in the USA, Brazil, and South Africa. The disparities previ-
ously existing in these countries have the potential to worsen
during the coronavirus pandemic. Against this background,
we reflect on the possible relationships between ethnicity
and COVID-19 outcomes, and factors influencing these out-
comes such as exposure and disease-predisposing comorbid-
ities across the three countries.
In Table 1, the top ten leading causes of death in 2019 are
presented for the three countries as reported by the Institute for
HealthMetrics and Evaluation [23].Worth noting is that some
of the causes of death which predate the pandemic also feature
as comorbidities of the COVID-19 virus infection. Across the
three countries, populations of specific ethnicities are prone to
the burden of communicable and noncommunicable diseases
[16–18, 24–26]. On the infectious disease front, HIV and TB
constitute a considerable fraction especially in South Africa.
South Africa had an estimated 7.7 million people living with
HIV in 2019 [27]. In Brazil and the USA, about 1.1 million
and 920,000 people, respectively, live with HIV [28, 29].
South Africa also features among the four countries that con-
tribute tomore than 40% of the global TB burden [30], with an
estimated 2017 TB incidence and mortality of 567 and 39 per
100,000, respectively [31]. Brazil’s cases were estimated to be
44 and 2.4 per 100 000 for incidence and mortality, respec-
tively [32] while the incidence rate in the USA for the same
year was 2.8 per 100,000 [33].
The COVID-19 Experience
Across the three countries, there were similarities and differ-
ences in the populations confirmed to be infected with the
coronavirus, as noted in hospitalization data. More females
were infected in the USA (51.7%) and South Africa (58.3%)
while in Brazil, more males were infected [7, 8, 11]. In South
Africa, the higher number of female cases may be due to
exposure in roles related to healthcare and teaching, along
with their health-seeking behaviors [34]. In the USA and
Brazil, confirmed infections were highest in the age groups
18–29 years (21.8%) and 60–69 years (20.5%), respectively
[8, 11]. In South Africa, the age groups 30–34 and 35–39
years accounted for 12.5 and 12.8% of cases, respectively,
which collectively comprised 25.3% of cases [34].
While more cases of confirmed infection were recorded
among females in South Africa and the USA, there were more
deaths among males. Across all three countries, those who
were more likely to develop severe disease were older indi-
viduals, males, and those with comorbidities [7–9].
Hypertension, diabetes mellitus, cardiovascular disease, and
obesity were some of the comorbidities reported with
COVID-19 hospitalization and death [7–9, 11]. In South
Africa, hypertension (29.1%) and diabetes (22.5%) were the
most common conditions in COVID-9 admissions. They were
also the most often reported comorbidities among individuals
who died aged 40 years and older while HIV was the most
common comorbidity among those between 20 and 39 years
old at the time of death. In individuals between 20 and 60
years old at the time of death, HIV, TB, and obesity were
commonly reported [7]. In Brazil, more than half (53.2%) of
those hospitalized for severe acute respiratory syndrome
(SARS) were positive for the COVID-19 virus. A minimum
of one comorbidity was reported by almost two thirds (63.9%)
of those who died over a period of 30 weeks [8]. Heart disease
(45.4% and 9.2% in individuals above and below 60 years,
respectively) and diabetes mellitus (33.6% and 9.0% in indi-
viduals above and below 60 years, respectively) were the most
frequent comorbidities among individuals who died [8]. In the
USA, hypertension (59.3%), obesity (47.0%), metabolic dis-
ease (42.9%), and cardiovascular disease (34.0%) were the
most frequently reported comorbidities among hospitalized
adult patients over a 3-month period [9]. The prevalence of
some infectious diseases such as HIV or TB, and their effect
on the pandemic has been noted. An increased prevalence of
underlying health conditions has been noted to contribute to
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higher COVID-19 mortality in people living with HIV in the
USA [35]. In South Africa, research also noted HIV as a risk
factor for COVID-19-related complication and mortality [36].
Figure 1 shows the cumulative number of confirmed infec-
tion cases (solid lines) and deaths (broken lines), since the start
of the pandemic till September 2020, across the three coun-
tries. Data for Fig. 1 were generated from the coronavirus
pandemic (COVID-19) data repository of Our World in
Data, a collaborative effort of different people and organiza-
tions [37]. As shown in the figure, the USA had the highest
record of cases and deaths and South Africa the least. This was
noted in absolute as well as proportional values (for instance,
cases per million population).
African countries, including South Africa, had earlier been
noted as outliers as it related to the pandemic course—case
fatalities did not earlier match expectations, especially consid-
ering the continent’s generally fragile healthcare system [38,
39]. Among the possible reasons for this are testing capacity
which likely lags infections, and the non-presentation (for
testing) of some infected/exposed individuals who may not
Table 1 Leading causes of death
(2019) across South Africa,
Brazil, and the USA [23]
Leading causes of death (year: 2019)
South Africa Brazil USA
1 HIV/AIDS Ischemic heart disease Ischemic heart disease
2 Ischemic heart disease Stroke Lung cancer
3 Stroke Lower respiratory infections COPD
4 Lower respiratory infections COPD Stroke
5 Diabetes Interpersonal violence Alzheimer’s disease
6 Tuberculosis Diabetes Chronic kidney disease
7 Road injuries Alzheimer’s disease Colorectal cancer
8 Interpersonal violence Road injuries Lower respiratory infection
9 Neonatal disorders Chronic kidney disease Diabetes




































Fig. 1 Confirmed COVID-19 virus infection cases (solid lines) and deaths (broken lines) up till 28 September 2020 in South Africa, Brazil, and the USA
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have access to healthcare or the wherewithal to isolate/
quarantine should such be indicated. More recent reports have
noted a seroprevalence of about 40% in specific populations
in South Africa [40]; further research will be helpful in pro-
viding more insight on COVID-19 virus prevalence in the
general population. Reports of excess deaths across the three
countries further supports the notion that confirmed infections
are a fraction of the actual pandemic scale [41–46].
The data on COVID-19 hospitalization and fatalities noted
some similarities across the three countries. In South Africa,
factors associated with mortality reflected age, gender, health
sector where admitted, comorbidity, and ethnic classifications.
Within the ethnic factors, being of Black African, Colored, or
Indian ethnicity was associated with in-hospital mortality [7].
In Brazil, an ethnicity effect was noted, where individuals of
Brown and Black ethnicity had increased risk of mortality [8,
10]. In the USA, rates for hospitalization (which can be taken
as indication of severe disease) were considerably higher for
minority populations: the prevalence ratio1 was higher for
those classified as American Indians/Alaskan Natives (1.9),
African Americans (1.8), and Hispanics/Latinos (1.6) com-
pared to Whites (0.5) [9].
The workplace has been noted to pose considerable
risk to African Americans and other minority populations
in the USA, where exposure has been considerable among
low-wage earners who are involved in essential work and
services in the current pandemic [47]. Many structural and
social factors expose these workers to the vulnerability of
the coronavirus infection which is compounded by their
preexis t ing under ly ing medica l condi t ions : for
instance, the need to work multiple jobs at different facil-
ities with high exposure potential for low wages contrib-
utes to increased exposure, illustrating the contribution of
social insecurity to coronavirus transmission [47]. In
Brazil, Black and Brown Brazilians have been noted to
comprise a considerable portion of essential workers who
are occupationally more exposed to infection [10]. South
Africa’s healthcare workers, like other health care workers
globally, have been noted to be among those occupation-
ally more exposed to the viral infection [48]. A consider-
able proportion of workers also transitioned to work-
from-home settings in South Africa, further highlighting
the importance of the workplace as a risk for transmission
[49]. The workplace therefore needs to be evaluated as a
potential key transmission venue, with interventions in
place to minimize transmission especially in common
work areas.
The spread of the viral infection across the three countries
share some similarities. Index cases were generally from
residents who had travelled to a country with confirmed in-
fections. Over time, cases spread from more affluent areas to
higher concentration among the socioeconomically vulnerable
who live in places and conditions where distancing, as advo-
cated for public health promotion and pandemic management,
may pose challenges. A consideration of such contextualities
will improve the application of public health models for infec-
tion mitigation.
The Way Forward
Further studies on overall case fatality among different ethnic
populations in all three countries can contribute to research-
informed findings. Worth noting in these considerations is the
age group with the highest prevalence of infections in Brazil
(20.5% in the 60 to 69 years group), along with other possible
associations [8]. It is very likely that across all three countries,
not all infected individuals presented to a healthcare facility
and this may limit the generalizability of study findings, both
within and outside the three countries. Data is also not avail-
able on the health seeking behavior, incidence of medical
pluralism, and type of supplementary treatment and remedies,
used by the infected or exposed individuals across the differ-
ent population and ethnic groups, perhaps even prior to hos-
pitalization, and how these may have influenced outcomes, if
at all. More research on these is required to inform mitigation
efforts, in this and similar future pandemics.
The COVID-19mortality among people of African descent
and some other minorities in the USA, Brazil and South
Africa may reflect their increased level of exposure to the
virus, burden of comorbidities, or challenges with access to
healthcare resources. These, in addition to other risk factors
that may have influenced pandemic outcomes, also require
further investigation. The pandemic seems to pose added pres-
sure on people of lower socioeconomic status (largely classi-
fied along ethnic lines) and those who were already battling
with socioeconomic pressures and chronic diseases in the time
preceding the pandemic. Public health campaigns during and
in the wake of the pandemic need to engage the population,
and effectively target those at increased risk due to age, co-
morbidities, ethnicity, socioeconomic status, and other perti-
nent factors, for sustainable and publicly owned infection pre-
vention and health promotion behaviors.
While work-related exposure, in addition to preexisting co-
morbidities, likely increases the risk of COVID-19 infection
and mortality among vulnerable populations, many of those
affected work in informal jobs where social and health security
may not be available. Their remuneration also does not afford
them the luxury to attend to pressing health matters, as they
may only be paid for worked hours. As such, their presentation
for healthcare attention, even in the context of COVID-19 dis-
ease, could be relatively late, which again delays diagnosis and
1 “Prevalence ratio is calculated as the ratio of the proportion of COVID-NET
hospitalizations over the proportion of population in the COVID-NET catch-
ment area” (reference number 9)
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appropriate management, increasing infection in vulnerable
communities, along with morbidity and mortality.
Through public health messages, the cost-effectiveness of
interventions such as physical distancing and sanitation in
flattening the curve of infection transmission to reduce ad-
verse outcomes in all settings have been highlighted.
However, these measures have been noted as privileges for
households who live in small spaces [50], and where access to
clean water supply, soap, and other sanitary measures may be
limited. Among these populations, the need to work for sus-
tenance may also override the need for compliance with phys-
ical distancing, especially for many informal workers who
head food-insecure households. Food and other related inse-
curities in these families were a reality that predated the cur-
rent pandemic and has only been magnified by the current
pandemic circumstances [51]. Social and economic inequity
may also result in multigenerational use of small living envi-
ronments, further exposing some in the higher-risk group (the
elderly) to the risk of infection. This risk may be obtained in
low-income areas (mostly classified along ethnic lines) across
all three countries.
Findings from studies in the USA indicate that underlying health
conditions alone may not be solely responsible for the disparity between
racial/ethnic groups in infection rate and mortality related to COVID-19.
These and some other reports from South Africa and Brazil have sug-
gested differences in exposure, age-specific incidence rates, and structural
healthdeterminantsassociatedwithspecificethnicities,assignificant factors
driving incidence and mortality [50, 52–56]. The larger proportion of
positive cases among African-descending individuals and some minority
populations in the three countriesmay be due to pervasive social inequal-
ities that increase exposure.These includebut are not limited to challenges
with implementing social distancing in lower socioeconomic status com-
munities [50, 52–56].
While infections may not yet have been fully contained,
data exist for preliminary analyses of infection, morbidity,
and mortality according to context. As the countries with rel-
atively high numbers of confirmed infections and mortality
across their respective continents, and with socioeconomic
differences along ethnic lines, there may be room for findings
that can inform pandemic control measures in other similar
settings. Recommendations by the Centers for Disease
Control and Prevention (CDC) on health equity consider-
ations [57] can serve as a guide for governments to apply
towards improving the life of vulnerable people in times of
crisis. Tracking of COVID-19 case and mortality data for
disparities in socioeconomic, gender, ethnic, geographic, and
other characteristics will help to improve the management of
patient groups as well as in resource allocation and design of
targeted public health information and interventions. In mul-
tiracial societies where inequities exist along ethnic lines, data
disaggregation by ethnicity and other pertinent characteristics
can be used to promote health equity.
An opportunity now exists to prepare for the next epidemic,
utilizing current experiences for health and disaster manage-
ment, with due consideration of disparities and how these can
be addressed. The ongoing pandemic has highlighted the im-
portance of addressing social health determinants, the impor-
tance of basic functional amenities in different sectors, and the
need for collective global effort in infection control.
Furthermore, it highlights the need for all economies to ad-
dress attainment of the Sustainable Development Goals
(SDGs) in member states. Accomplishing these would help
to narrow disparities in various sectors of the economy and the
population. The current pandemic has also emphasized the
benefits of multidisciplinary and multisectoral coordination
for pandemic containment and mitigation. Essentially, all
stakeholders, including the public, should be made aware of
the probability that the COVID-19 virus infection may not be
a once-off occurrence but may reoccur over seasons. As such,
long-term sustainable actions are required for future contain-
ment and mitigation.
Limitations of the Study
This extended commentary presents data on COVID-19-
related hospitalization and mortality among different ethnici-
ties across three countries in high- and middle-income set-
tings. Its findings are subject to at least four limitations which
must be considered in the presented inferences. Firstly, the
information presented on hospitalization and mortality (“The
COVID-19 Experience” section) is based on data from hospi-
talization cases, with data on ethnicity not necessarily avail-
able for all hospitalized patients. Secondly, because the find-
ings on confirmed cases and mortality are informed by
hospitalization-level data, such findings may not
necessarily account for data on infected individuals attended
to in other healthcare facilities (non-hospital settings) or those
who may have had COVID-19-related complications outside
of hospital settings, for instance, in their homes. Thirdly, this
manuscript excludes seroprevalence data across the three
countries. While the records show a relatively lower number
of confirmed coronavirus infections in South Africa, com-
pared to Brazil and the USA, it is worth noting that the out-
break in South Africa commenced later. The differences in
pandemic commencement dates may have influenced pan-
demic mitigation and hence epidemiological profiles. A fourth
limitation stems from the presentation of information on the
first wave of infections in each country. Subsequent waves
have arisen, as in many other parts of the world, with out-
comes which have not been accounted for in this commentary.
In addition, while healthcare accessibility and COVID-19 vi-
rus exposure may differ among populations, contextual details
could have further influenced COVID-19 outcomes in the
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three countries. However, in this study, we did not explore
these aspects which poses further limitation.
Nevertheless, this manuscript presents some preliminary
data which can be used to initiate discussions related to the
influence of social health determinants on COVID-19 and
other health outcomes. During and at the end of the pandemic,
it will be necessary to evaluate how exposure, preexisting
social factors, and interventions put in place, affected the ep-
idemiological course, generally and among specific popula-
tions. The need also exists to explore continued health dispar-
ities which existed before, and which can be enhanced by
pandemics such as the current coronavirus, and account for
the effect of these to allow for contextual comparisons of
infectious disease data where needed.
Conclusion/Recommendations
Individuals of African descent and some minority populations
have been noted to be more vulnerable to adverse COVID-19
outcomes in multiracial societies. This is thought to reflect a
combination of disparities in exposure, and health and health
care access, as a result of their occupational and socioeconom-
ic backgrounds. Social determinants of health need to be ad-
dressed to reduce health and related inequities, with the ex-
pansion of the public healthcare system for more focus on
chronic disease prevention and control, especially in vulnera-
ble populations. On the heels of public health and other mea-
sures for containment and mitigation of the COVID-19
virus pandemic, sustained discussions on social, political, eco-
nomic, and ethnic health determinants among all stakeholders
is necessary for overall improvement in health and healthcare.
Adherence to the World Health Organization’s recommenda-
tion for social justice, as prerequisite for health [58], is crucial
to reduce health disparities by addressing social inequality to
transform health inequities. Failure to address these issues will
leave current and new poor people and communities more
vulnerable to public health crises in future pandemics.
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